Clinical benefits of ultrapure dialysis fluid for hemodialysis

Hemodialysis International

Volumn 11, Issue SUPPL. 1, 2007, Pages

  Ledebo, Ingrid ^a  

^a Gambro AB   (Sweden)

Author keywords

Biocompatibility; Dialysate; Dialysis fluid; Hemodialysis; Inflammation; Ultrapure

Indexed keywords

ADVANCED GLYCATION END PRODUCT; BETA 2 MICROGLOBULIN; C REACTIVE PROTEIN; DIALYSIS FLUID; ERYTHROPOIETIN; HEMOGLOBIN; INTERLEUKIN 6;

ANEMIA; ARTICLE; AWARENESS; BACTERIUM; BIOCOMPATIBILITY; CARPAL TUNNEL SYNDROME; COLONY FORMING UNIT; DIALYSIS MEMBRANE; HEMODIALYSIS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INCIDENCE; INFLAMMATION; KIDNEY FUNCTION; NONHUMAN; QUALITY CONTROL; ULTRAFILTRATION;

EID: 33947722247     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2007.00141.x     Document Type: Article

References (32)

1. Henderson L, Ward RA, Mion CM, et al. Should hemodialysis fluid be sterile? Semin Dial. 1993; 6:26-36.
2. Ward RA, Sadler JH. Microbiological quality requirements for dialysate: Is it time for a change. Nephrol News Issues. 2002; 11:26, 28-29, 33-34, 36, 38, 40, 73.
3. Bommer J, Jaber BL. Ultrapure dialysate: Facts and myths. Semin Dial. 2006; 19:115-119.
4. European best practice guidelines for haemodialysis (Part 1), Section IV. Dialysis fluid purity. Nephrol Dial Transplant. 2002; 17(Suppl 7):46-62.
5. Ledebo I, Nystrand R. Defining the microbiological quality of dialysis fluid. Artif Organ. 1999; 23:37-43.
6. Ledebo I. On-line preparation of solutions for dialysis: Practical aspects versus safety and regulations. J Am Soc Nephrol. 2002; 13(Suppl 1):S78-S83.
7. Ward RA. Ultrapure dialysate. Semin Dial. 2004; 17:489-497.
8. Ledebo I. Ultrapure dialysis fluid: Improving conventional and daily dialysis. Hemodial Int. 2004; 8:159-166.
9. Baz M, Durand C, Ragon A, et al. Using ultrapure water in hemodialysis delays carpal tunnel syndrome. Int J Artif Organ. 1991; 14:681-685.
10. Kleophas W, Haastert B, Backus G, Hilgers P, Westhoff A, van Endert G. Long-term experience with an ultrapure individual dialysis fluid with a batch type machine. Nephrol Dial Transplant. 1998; 13:3118-3125.
11. Lonnemann G, Behme TC, Lenzner B, et al. Permeability of dialyzer membranes to TNF α-inducing substances derived from water bacteria. Kidney Int. 1992; 42:61-68.
12. Schwalbe S, Holzhauer M, Schaeffer J, Galanski M, Koch K-M, Floege J. β 2 -microglobulin associated amyloidosis: A vanishing complication of long-term hemodialysis? Kidney Int. 1997; 52:1077-1083.
13. Lonnemann G. The quality of dialysate: An integrated approach. Kidney Int. 2000; 58(Suppl 76): S112-S119.
14. Schindler R, Lonnemann G, Schäffer J, Shaldon S, Koch KM, Krautzig S. The effect of ultrafiltered dialysate on the cellular content of interleukin-1 receptor antagonist in patients on chronic hemodialysis. Nephron. 1994; 68:229-233.
15. Quellhorst E. Hämodialyseverfahren. Nieren-Hochdruckkrkh. 1998; 27:S35-S41.
16. Sitter T, Bergner A, Schiffl H. Dialysate related cytokine induction and response to recombinant human erythropoietin in haemodialysis patients. Nephrol Dial Transplant. 2000; 15:1207-1211.
17. Schiffl H, Lang SM, Stratakis D, Fischer R. Effects of ultrapure dialysis fluid on nutritional status and inflammatory parameters. Nephrol Dial Transplant. 2001; 16:1863-1869.
18. Matsuhashi N, Yoshioka T. Endotoxin-free dialysate improves response to erythropoietin in hemodialysis patients. Nephron. 2002; 92:601-604.
19. Rahmati MA, Homel P, Hoenich NA, Levin R, Kaysen GA, Levin NW. The role of improved water quality on inflammatory markers in patients undergoing regular dialysis. Int J Artif Organs. 2004; 27:723-727.
20. Arizono K, Nomura K, Motoyama T, et al. Use of ultrapure dialysate in reduction of chronic inflammation during hemodialysis. Blood Purif. 2004; 22(Suppl 2):26-29.
21. Hsu P-Y, Lin C-L, Yu C-C, et al. Ultrapure dialysate improves iron utilization and erythropoietin response in chronic hemodialysis patients - a prospective cross-over study. J Nephrol. 2004; 17:693-700.
22. 2-microglobulin and pentosidine in hemodialysis patients. Blood Purif. 2005; 23:311-316.
23. Schouten WEM, Grooteman MPC, van Houte A-J, Schoorl M, van Limbeck J, NubéMJ. Effects of dialyser and dialysate on the acute phase reaction in clinical bicarbonate dialysis. Nephrol Dial Transplant. 2000; 15:379-384.
24. van Tellingen A, Grooteman MPC, Schoorl M, et al. Intercurrent clinical events are predictive of plasma C-reactive protein levels in hemodialysis patients. Kidney Int. 2002; 62:632-638.
25. Schindler R, Boenisch O, Fischer C, Frei U. Effect of the hemodialysis membrane on the inflammatory reaction in vivo. Clin Nephrol. 2000; 53:452-459.
26. Izuhara Y, Miyata T, Saito K, et al. Ultrapure dialysate decreases plasma pentosidine, a marker of "carbonyl stress." Am J Kidney Dis. 2004; 6:1024-1029.
27. Gerdemann A, Wagner Z, Solf A, et al. Plasma levels of advanced glycation end products during haemodialysis, haemodiafiltration and haemofiltration: Potential importance of dialysate quality. Nephrol Dial Transplant. 2002; 17:1045-1049.
28. McKane W, Chandna SM, Tattersall JE, Greenwood RN, Farrington K. Identical decline of residual renal function in high-flux biocompatible hemodialysis and CAPD. Kidney Int. 2002; 61:256-265.
29. Schiffl H, Lang SM, Fischer R. Ultrapure dialysis fluid slows loss of residual renal function in new dialysis patients. Nephrol Dial Transplant. 2002; 17:1814-1818.
30. Bologa RM, Levine DM, Parker TS, et al. Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia and mortality in hemodialysis patients. Am J Kidney Dis. 1998; 32:107-114.
31. Wanner C, Zimmermann J, Schwedler S, Metzger Inflammation and cardiovascular risk in dialysis patients. Kidney Int. 2002; 62(Suppl 80):S99-S102.
32. Wang AY-M, Lai K-N. The importance of residual renal function in dialysis patients. Kidney Int. 2006; on-line advance print.